Business
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich., June 25, 2025--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.
About this update from Stryker Corporation
[{"type":"image","alt":"Stryker's Incompass® Total Ankle System integrates the technologies of the Inbone® and Infinity® systems into a single, comprehensive solution.","displaySize":"","headline":null,"caption":"Stryker's Incompass® Total Ankle System integrates the technologies of the Inbone® and Infinity® systems into a single, comprehensive solution.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":288,"url":"https://media.zenfs.com/en/business-wire.com/c13a991a872761e8167bf2d57586aa47"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XoyKIh0XJH2LSVPE.JJm0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU3NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c13a991a872761e8167bf2d57586aa47","width":480,"height":288}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":319,"url":"https://media.zenfs.com/en/business-wire.com/18930c1ce5e339c43cf64b680dd6798e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_ac1nXreC0hYUTtAIeaYfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1NTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/18930c1ce5e339c43cf64b680dd6798e","width":960,"height":255},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Rf1jVy7H5OP7C2RvBToy.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Mzg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/18930c1ce5e339c43cf64b680dd6798e","width":1200,"height":319}}},{"type":"text","content":"Streamlining total ankle replacement with data-driven implants and surgical flexibility","length":87,"tagName":"p"},{"type":"text","content":"PORTAGE, Mich., June 25, 2025--(BUSINESS WIRE)--Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® Total Ankle System, an implant intended for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis. This new platform integrates the innovative technologies of Stryker’s Inbone® and Infinity® systems into a single, comprehensive solution for total ankle replacement.","length":521,"tagName":"p"},{"type":"text","content":""Incompass reflects our commitment to redefining what’s possible in total ankle replacement," said ...